During the past decade, Ege Universitesi Tip Fakultesi Tibbi Onkoloji Bilim Dali conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ege Universitesi Tip Fakultesi Tibbi Onkoloji Bilim Dali" are "Breast Neoplasms" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Ege Universitesi Tip Fakultesi Tibbi Onkoloji Bilim Dali" in a lesser frequency.

Most popular intervention types in "Ege Universitesi Tip Fakultesi Tibbi Onkoloji Bilim Dali" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BIBW 2992" (1 trials), "afatinib" (1 trials), "erlotinib" (1 trials), "trastuzumab" (1 trials) and "vinorelbine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ege Universitesi Tip Fakultesi Tibbi Onkoloji Bilim Dali" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ege Universitesi Tip Fakultesi Tibbi Onkoloji Bilim Dali". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ege Universitesi Tip Fakultesi Tibbi Onkoloji Bilim Dali, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ege Universitesi Tip Fakultesi Tibbi Onkoloji Bilim Dali, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".